BRPI0921917B8 - formulação farmacêutica. - Google Patents
formulação farmacêutica.Info
- Publication number
- BRPI0921917B8 BRPI0921917B8 BRPI0921917A BRPI0921917A BRPI0921917B8 BR PI0921917 B8 BRPI0921917 B8 BR PI0921917B8 BR PI0921917 A BRPI0921917 A BR PI0921917A BR PI0921917 A BRPI0921917 A BR PI0921917A BR PI0921917 B8 BRPI0921917 B8 BR PI0921917B8
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical formulation
- fatty acid
- acid group
- carbon atoms
- fat emulsion
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 208000028399 Critical Illness Diseases 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000005313 fatty acid group Chemical group 0.000 abstract 2
- 239000002960 lipid emulsion Substances 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 208000021642 Muscular disease Diseases 0.000 abstract 1
- 201000009623 Myopathy Diseases 0.000 abstract 1
- 206010036105 Polyneuropathy Diseases 0.000 abstract 1
- 230000007824 polyneuropathy Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008057867A DE102008057867A1 (de) | 2008-11-18 | 2008-11-18 | Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten |
| DE102008057867.3 | 2008-11-18 | ||
| PCT/EP2009/064839 WO2010057804A1 (de) | 2008-11-18 | 2009-11-09 | Fettemulsion zur künstlichen ernährung von schwerkranken intensivpatienten |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0921917A2 BRPI0921917A2 (pt) | 2015-12-29 |
| BRPI0921917B1 BRPI0921917B1 (pt) | 2020-08-25 |
| BRPI0921917B8 true BRPI0921917B8 (pt) | 2021-05-25 |
Family
ID=41581163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0921917A BRPI0921917B8 (pt) | 2008-11-18 | 2009-11-09 | formulação farmacêutica. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20110207819A1 (enExample) |
| EP (1) | EP2355813B1 (enExample) |
| JP (1) | JP2012509292A (enExample) |
| KR (1) | KR20110084513A (enExample) |
| CN (1) | CN102215839B (enExample) |
| BR (1) | BRPI0921917B8 (enExample) |
| CA (1) | CA2739390C (enExample) |
| DE (1) | DE102008057867A1 (enExample) |
| ES (1) | ES2561207T3 (enExample) |
| MX (1) | MX338223B (enExample) |
| RU (1) | RU2528108C2 (enExample) |
| WO (1) | WO2010057804A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102009013914B4 (de) * | 2009-03-19 | 2011-05-05 | Bruker Daltonik Gmbh | Kalibriersubstanzen für Atmosphärendruck-Ionenquellen |
| US20130296425A1 (en) * | 2011-01-31 | 2013-11-07 | Nagoya Industrial Science Research Institute | Prophylactic or therapeutic agent for a peripheral nerve disorder induced by anti-cancer agents |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| CN106900888B (zh) * | 2015-12-23 | 2021-12-24 | 丰益(上海)生物技术研发中心有限公司 | 含有奇数碳脂肪酸结构脂的油脂组合物及其应用 |
| WO2017211274A1 (en) * | 2016-06-08 | 2017-12-14 | Dong Yuhong | Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement |
| CN109602704A (zh) * | 2019-01-23 | 2019-04-12 | 广东嘉博制药有限公司 | 丁酸氯维地平脂肪乳注射液及其制备工艺 |
| CN110326789A (zh) * | 2019-06-11 | 2019-10-15 | 上海互众药业有限公司 | 一种脂肪乳食品补充液及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2515174A1 (fr) | 1981-10-23 | 1983-04-29 | Roussel Uclaf | Nouveaux triglycerides, procede de preparation et d'applications en dietetique et en therapeutique |
| US4526902A (en) | 1983-10-24 | 1985-07-02 | Century Laboratories, Inc. | Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions |
| DE3721137A1 (de) | 1987-06-26 | 1989-01-05 | Dietl Hans | Fettemulsion zur intravenoesen anwendung |
| DE3722540A1 (de) | 1987-07-08 | 1989-01-19 | Fresenius Ag | Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung |
| DE3734147C2 (de) * | 1987-10-09 | 1998-10-29 | Braun Melsungen Ag | Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung |
| AU682894B2 (en) * | 1993-10-28 | 1997-10-23 | Institut National De La Recherche Agronomique | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
| RU2155612C2 (ru) * | 1997-01-30 | 2000-09-10 | Скрипченко Наталия Викторовна | Способ лечения острых инфекционных заболеваний периферической нервной системы |
| CN101574335A (zh) * | 1999-02-05 | 2009-11-11 | 贝勒研究院 | 含七碳脂肪酸甘油三酯的营养补充剂或药物制剂 |
| US20030162833A1 (en) * | 2001-08-01 | 2003-08-28 | Roe Charles R. | Fatty acid treatment for cardiac patients |
| US6740679B1 (en) | 1999-02-05 | 2004-05-25 | Baylor University Medical Center | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| KR20050035151A (ko) * | 2001-10-11 | 2005-04-15 | 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. | 당뇨성 신경병증에서 ｇｐ130 활성인자의 용도 |
| US8399515B2 (en) * | 2003-05-20 | 2013-03-19 | Baylor Research Institute | Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| US8106093B2 (en) * | 2004-07-02 | 2012-01-31 | Baylor Research Institute | Glycogen or polysaccharide storage disease treatment method |
| EP1723944B1 (de) * | 2005-02-16 | 2007-04-04 | Dr. Streatmans Chemische Produktion GmbH | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an chemischen UV-Filtern und Triheptanonin |
| KR20090074221A (ko) | 2006-09-26 | 2009-07-06 | 베일러 리서치 인스티튜트 | 영양물 센서 |
-
2008
- 2008-11-18 DE DE102008057867A patent/DE102008057867A1/de not_active Withdrawn
-
2009
- 2009-11-09 KR KR1020117010418A patent/KR20110084513A/ko not_active Ceased
- 2009-11-09 BR BRPI0921917A patent/BRPI0921917B8/pt active IP Right Grant
- 2009-11-09 EP EP09760502.6A patent/EP2355813B1/de active Active
- 2009-11-09 RU RU2011124887/15A patent/RU2528108C2/ru active
- 2009-11-09 JP JP2011536823A patent/JP2012509292A/ja active Pending
- 2009-11-09 MX MX2011005201A patent/MX338223B/es active IP Right Grant
- 2009-11-09 ES ES09760502.6T patent/ES2561207T3/es active Active
- 2009-11-09 CA CA2739390A patent/CA2739390C/en active Active
- 2009-11-09 US US13/126,245 patent/US20110207819A1/en not_active Abandoned
- 2009-11-09 WO PCT/EP2009/064839 patent/WO2010057804A1/de not_active Ceased
- 2009-11-09 CN CN200980145702.6A patent/CN102215839B/zh not_active Ceased
-
2015
- 2015-11-03 US US14/930,723 patent/US20160051506A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2528108C2 (ru) | 2014-09-10 |
| CN102215839B (zh) | 2016-08-24 |
| BRPI0921917A2 (pt) | 2015-12-29 |
| CA2739390A1 (en) | 2010-05-27 |
| US20160051506A1 (en) | 2016-02-25 |
| CN102215839A (zh) | 2011-10-12 |
| WO2010057804A1 (de) | 2010-05-27 |
| CA2739390C (en) | 2016-05-03 |
| BRPI0921917B1 (pt) | 2020-08-25 |
| US20110207819A1 (en) | 2011-08-25 |
| DE102008057867A1 (de) | 2010-05-20 |
| MX338223B (es) | 2016-04-08 |
| ES2561207T3 (es) | 2016-02-25 |
| JP2012509292A (ja) | 2012-04-19 |
| EP2355813A1 (de) | 2011-08-17 |
| KR20110084513A (ko) | 2011-07-25 |
| RU2011124887A (ru) | 2012-12-27 |
| EP2355813B1 (de) | 2015-11-04 |
| MX2011005201A (es) | 2011-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0921917B8 (pt) | formulação farmacêutica. | |
| CU20140151A7 (es) | Composición farmacéutica útil en la prevención de un evento cardiovascular mayor | |
| BR112016029271A2 (pt) | forma sólida de dosagem oral de compostos lipofílicos | |
| BRPI0901513B8 (pt) | conjunto de embalagem | |
| BRPI0915536A2 (pt) | salicilatos acetilados de ácidos graxos e seus usos | |
| BR112015006942A2 (pt) | chocolate resistente a calor | |
| BRPI0514026A (pt) | composição contendo estatinas e ácidos graxos Èmega-3 | |
| BR112014027204A2 (pt) | conjugados d ácido graxo de estatina e agonistas fxr; composições e método de usos | |
| BR112016010422A8 (pt) | suplemento dietético, e uso de uma composição | |
| CL2011002268A1 (es) | Uso de compuestos derivados de acidos grasos poliinsaturados para el tratamiento de enfermedades neurodegenerativas y neurologicas; y composicion farmaceutica o nutraceutica. | |
| BR112015012739A2 (pt) | sistemas e métodos de guia ortopédico | |
| BR112012014967A2 (pt) | composição clara ou translúcia | |
| BR112014030344A2 (pt) | lembretes de ciência de localização | |
| BR112013000913A2 (pt) | dispositivo de estimativa de número de terminal e método de estimativa de número de terminal | |
| ES2629407T3 (es) | Soluciones acuosas que contienen un agente complejante en alta concentración | |
| BR112017012562A2 (pt) | lubrificante para alta temperatura para a indústria alimentícia | |
| BR112018000242A2 (pt) | composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico | |
| BR112017006416A2 (pt) | composição nutricional para meio gastrointestinal para proporcionar perfil aperfeiçoado de microbioma e metabólico | |
| BR112015029897A2 (pt) | composição sólida para administração oral contendo ácido ibandrônico ou um seu sal farmaceuticamente aceitável e vitamina d e processo para obtenção da referida composição | |
| BR112012017202A2 (pt) | composição transparente ou translúcida | |
| BR112017008033A2 (pt) | composição farmacêutica para administração oral e respectivo processo de preparação | |
| BR112015008777A2 (pt) | composição para emulsão de água em óleo | |
| BRPI0801054A2 (pt) | frasco para o acondicionamento de um produto | |
| BR112014017048A8 (pt) | emulsão orgânica compreendendo dha e epa | |
| BR112018077500A2 (pt) | alimento animal que compreende uma composição de ácido graxo poli-insaturado ômega-3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/225 (2006.01), A23L 33/12 (2016.01), A61K |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/08/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/11/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |